cdmo.directory
← Compare landing

IDT Australia vs Quotient Sciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/idtaus-com/quotientsciences

CategoryIDT AustraliaQuotient Sciences
Listed sitecdmocdmo
SummaryIDT Australia is a cGMP CDMO delivering end-to-end pharmaceutical development and manufacturing services from active pharmaceutical ingredients to finished dosage forms, with expertise in small molecule APIs, specialty orals, advanced therapies, and integrated regulatory support.Integrated CDMO offering drug product formulation and manufacturing for small molecules and synthetic peptides, with 30+ years of experience and scalable capacity from clinical to 500 kg commercial batches across US and UK facilities.
Services
  • HPAPI Manufacturing (High-Potency)
  • Process Development
  • Secondary Packaging & Labeling
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • ADC Payload & Linker Synthesis
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Formulation Development
  • Oral Solid Dosage Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Regulatory Affairs
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Technology Transfer
  • Oral Solid Dosage Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Small Molecule Development & Manufacturing
  • Peptide Manufacturing
Modalities
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
  • Small Molecule
  • Peptide
Indications
  • Neurology
  • Metabolic
  • Ophthalmology
Data not yet provided.
Locations
  • Headquarters, Australia
  • Headquarters, Nottingham, Nottinghamshire, UK
  • Clinical Pharmacology & Data Sciences, Miami, Florida, USA
  • Manufacturing & Formulation Development, Boothwyn, Pennsylvania, USA
  • Formulation Development & Clinical Trial Manufacturing, Garnet Valley, Pennsylvania, USA
  • Data Sciences Center, Edinburgh, Scotland, UK
  • Drug Substance Manufacturing (Arcinova), Alnwick, Northumberland, UK
  • Drug Substance Manufacturing & Bioanalysis, Alnwick, Northumberland, UK
  • Garnet Valley, Garnet Valley, Pennsylvania, United States
  • Boothwyn, Boothwyn, Pennsylvania, United States
  • Reading, Reading, England, United Kingdom
  • Miami, Miami, Florida, United States
  • Nottingham, Nottingham, England, United Kingdom
CertificationsData not yet provided.
  • FDA · Identifier: United States Food and Drug Administration
  • PMDA · Identifier: Japanese Pharmaceuticals & Medical Devices Agency
  • ANVISA · Identifier: Brazilian Health Regulatory Agency
  • NMPA · Identifier: Chinese National Medical Products Administration
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.